• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER VASCULAR PLUG; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER VASCULAR PLUG; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number 9-PLUG-006
Device Problem Human-Device Interface Problem (2949)
Patient Problems Myocardial Infarction (1969); Occlusion (1984)
Event Type  Injury  
Manufacturer Narrative
As reported in a research article, a patient underwent a transcatheter closure of a coronary-cameral fistula using two amplatzer vascular plugs sometime between june 2002 and december 2017.Six months post procedure an event of middle right coronary artery chronic total occlusion and inferior wall myocardial infarction was reported.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
The article, " transcatheter closure of large coronary-cameral fistulas using the patent ductus arteriosus occluder or amplatzer vascular plugs" was reviewed this research article reported a (b)(6) year old male with a large congenital coronary-cameral fistula(ccf) who underwent successful transcatheter closure(tcc) using a 6mm and 8mm amplatzer vascular plug(avp) sometime between june 2002 to december 2017.A multidetector computed tomography was performed 6 months post-procedure and showed middle right coronary artery(rca) chronic total occlusion and the ecg showed old inferior wall myocardial infraction.The patient was asymptomatic and treated with aspirin indefinitely.The article concluded that tcc of large sized ccf's using the patent ductus arteriosus occluder or avp is a safe and effective therapy in anatomically suitable candidates, with favorable long-term outcomes.The primary author of the article is liang tang, md, department of cardiology, the second xiangya hospital of central south university, changsha, china.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER VASCULAR PLUG
Type of Device
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
pamela yip
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key11098908
MDR Text Key225816372
Report Number2135147-2020-00560
Device Sequence Number1
Product Code KRD
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K031810
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 12/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/30/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9-PLUG-006
Device Catalogue Number9-PLUG-006
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received12/07/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age3 YR
-
-